LONG MINI-FUTURE - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VV64KY2

Market Closed - Deutsche Boerse AG 18:41:48 01/07/2024 BST
13.48 EUR +1.13% Intraday chart for LONG MINI-FUTURE - FRESENIUS MEDICAL CARE
Current month+1.13%
1 month-19.90%
Date Price Change
01/07/24 13.48 +1.13%
28/06/24 13.33 0.00%
27/06/24 13.33 +0.45%
26/06/24 13.27 -0.15%
25/06/24 13.29 -3.28%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 06:41 pm

More quotes

Static data

Product typeKnock-Out con Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VV64KY
ISINDE000VV64KY2
Date issued 23/09/2022
Strike 22.47
Maturity Unlimited
Parity 1 : 1
Emission price 9.03
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 27.64
Lowest since issue 4.41

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.88 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.41%
Consensus